Algo version: 0.98b
Taisho Pharmaceutical is listed at the OTC Exchange
Taisho Pharmaceutical [TAIPY]
OTC Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Taisho Pharmaceutical stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Taisho Pharmaceutical pays dividends. Last time was Monday 18th of December 2023 where the investors holding the stock on Thursday 28th of September 2023 were paid $0.08508 per share. Over the last 6 times between 2021 and 2023, Taisho Pharmaceutical has paid $0.577551 with an average of $0.1 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Taisho Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $17.35, you would have made a loss of $-5.35 per share or -30.84%

No, the average daily trading liquidity for Taisho Pharmaceutical is $202 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Taisho Pharmaceutical has no real debt, which is good in periods of high inflation. The company has a very low net profit margin of 2.63%, which is challenging.

We have calculated the inflation risk for Taisho Pharmaceutical to be low [0.5 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.